LMLouise Merle

Louise Merle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise Merle has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CD4+ T cell–T cell interactions preserve clonal diversity to recognize antigen variants

    by Olivier Lantz, Hugo Roux, Vadim Karnaukhov, Sol-Yanel Nunez, Rafael Paiva, Morgane Ducastel, Aurelie Darbois, Anastasia du Halgouet, Christina Ekwegbara, Erwan Verluise, et al.

    Recruitment of diverse antigen-specific T-cell clones is essential for effective CD4+ T cell immunity, enhancing the robustness of responses to antigenic variation. However, because CD4+ T cell proliferation requires repeated antigen encounter1,2 and peptide–MHC-II complexes are long-lived in vivo3, sustained stimulation is expected to preferentially expand the clones with the highest TCR avidity4, thereby reducing clonal diversity. Yet, CD4+ T cell responses in vivo remain remarkably diverse5–8. The mechanisms that preserve clonal diversity during T cell expansion remain poorly understood. Here, we provide in vivo evidence for antigen-specific CD4+ T cell–T cell (T–T) contacts and demonstrate that SOCS1-dependent inhibition of antigen-experienced CD4+ T cell proliferation preserves repertoire diversity during an ongoing immune response. Mathematical modelling predicted that such T–T contacts can maintain a diverse response by limiting preferential expansion of the most avid clones. Inducible SOCS1 disruption validated this prediction by converting the response into an oligoclonal expansion dominated by a few high-avidity clones. Large-scale experimental measurements of TCR avidity and antigen-variant recognition showed that wild-type repertoires retain clones spanning a broad avidity range and complementary cross-reactivity profiles. A sequence-based machine-learning model extended these measurements to whole repertoires, revealing broader coverage of antigenic variation in wild-type than in SOCS1-deficient responses, a prediction confirmed experimentally by recall responses to antigen variants. Simulations further showed that the size of wild-type expanded repertoires lies within the range predicted to achieve near-optimal coverage of antigenic variation. Thus, antigen-specific T cell–T cell interactions and SOCS1 signaling control TCR diversity and improve the adaptability of CD4+ T cell immunity to antigenic variation.

  • Open Access

    LUCID-EV: a robust and quantitative bioluminescent assay for the detection of EV cytosolic delivery in the absence of VSV-G expression

    by Louise Merle, Lorena Martin-Jaular, Clotilde Thery, Alain Joliot

    Extracellular vesicles are key intercellular messengers that modulate the function of target cells by carrying effectors, either at their surface or in their lumen. In the latter case, their action depends on the ability to deliver their content into the cytosol of target cells. How efficiently EVs deliver their content upon interaction with their target cell is thus a central question for understanding the functional impact of this mode of action. To address this question, signal-driven bimolecular interactions between two partners located respectively in the EV lumen and the target cell cytosol have become a widely used strategy to detect the cytosolic delivery EV content. However, the detection of cytosolic delivery with these assays was often tributary to the artificial enhancement of the fusion between EV and cell membranes, through for instance VSV-G fusogenic protein expression. Here we provide a robust and quantitative LUCiferase-based complementation assay (HiBiT/LgBiT), to quantify the Internalization and cytosolic Delivery of EV content: LUCID-EV. By optimizing the signal-to-noise ratio of the assay, the method for loading HiBiT fragment into EVs (fusion to a lipid-binding domain rather than to tetraspanins), and the intracellular position of LgBiT (associated to membranes), we could quantify cytosolic delivery from various non-VSV-G-expressing EVs into target immune dendritic cells. Importantly, this delivery did not involve the acidic late endosomes environment required for VSV-G-dependent EV cytosolic delivery. The limited efficacy of the process highlights the need for highly sensitive assays like the one described here. Further development of the LUCID-EV assay could help identifying EV/target cells pairs with enhanced cytosolic delivery properties and characterize the cellular route for delivery.

  • Open Access

    Extracellular vesicles and co‐isolated endogenous retroviruses from murine cancer cells differentially affect dendritic cells

    by Federico Cocozza, Lorena Martin‐Jaular, Lien Lippens, Aurelie Di Cicco, Yago A Arribas, Nicolas Ansart, Florent Dingli, Michael Richard, Louise Merle, Mabel Jouve San Roman, et al.

    Cells secrete extracellular vesicles (EVs) and non-vesicular extracellular (nano)particles (NVEPs or ENPs) that may play a role in intercellular communication. Tumor-derived EVs have been proposed to induce immune priming of antigen presenting cells or to be immuno-suppressive agents. We suspect that such disparate functions are due to variable compositions in EV subtypes and ENPs. We aimed to characterize the array of secreted EVs and ENPs of murine tumor cell lines. Unexpectedly, we identified virus-like particles (VLPs) from endogenous murine leukemia virus in preparations of EVs produced by many tumor cells. We established a protocol to separate small EVs from VLPs and ENPs. We compared their protein composition and analyzed their functional interaction with target dendritic cells. ENPs were poorly captured and did not affect dendritic cells. Small EVs specifically induced dendritic cell death. A mixed large/dense EV/VLP preparation was most efficient to induce dendritic cell maturation and antigen presentation. Our results call for systematic re-evaluation of the respective proportions and functions of non-viral EVs and VLPs produced by murine tumors and their contribution to tumor progression.